FIELD: ophthalmology.
SUBSTANCE: invention relates to the treatment of corneal defects of various etiologies. Blood is drawn from a vein of the patient using a sterile APM blood processing tube intended to obtain platelet-rich plasma. The resulting platelet-rich plasma is placed in a sterile container and incubated at a room temperature for 15–30 minutes until a clot is formed, from which a platelet-fibrin film with a thickness of 0.2–0.3 mm and a diameter of 10– 11 mm is formed with platelet content in a concentration of at least 1.0–1.1×109 cells/l, which is placed on the cornea and fixed with a soft contact lens.
EFFECT: invention provides a reduction in the treatment duration.
3 cl, 4 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING CORNEAL DEFECTS VIA AN AUTOLOGOUS THROMBOFIBRIN CLOT | 2019 |
|
RU2699206C1 |
| METHOD FOR SURGICAL TREATMENT OF CORNEAL DEFECTS OF VARIOUS ORIGINS | 2022 |
|
RU2782129C1 |
| METHOD OF COMBINED FIXATION OF AMNIOTIC MEMBRANE FOR TREATMENT OF CHRONIC CORNEAAL EROSIONS | 2023 |
|
RU2807860C1 |
| METHOD FOR BIOCOATING OF INJURED CORNEA | 2023 |
|
RU2813951C1 |
| METHOD FOR DIFFERENTIATED TREATMENT OF CORNEAL EROSIONS AND ULCERS | 2021 |
|
RU2765601C1 |
| METHOD FOR PREVENTING KERATOTRANSPLANT LYSIS IN URGENT SURGERY | 2023 |
|
RU2822412C1 |
| METHOD OF TREATMENT OF CORNEAL GRAFT DEFECTS WITH DELAYED EPITHELIALIZATION USING SCLERAL CONTACT LENSES | 2022 |
|
RU2801489C1 |
| METHOD FOR TREATING CHRONIC CORNEAL EROSIONS | 2021 |
|
RU2776218C1 |
| METHOD OF TREATING INFLAMMATORY OR DYSTROPHIC EYE DISEASES | 2019 |
|
RU2714193C1 |
| TREATMENT METHOD FOR CHRONIC CORNEA EROSIONS OF HERPETIC ETHIOLOGY | 2017 |
|
RU2653260C1 |
